67 related articles for article (PubMed ID: 32697965)
1. Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Junginger T; Hermanek P; Merkel S;
J Am Coll Surg; 2020 Oct; 231(4):413-425.e2. PubMed ID: 32697965
[TBL] [Abstract][Full Text] [Related]
2. MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
Zeng Z; Li Z; Luo S; Huang L; Liang Z; Zheng X; Li W; Xiong L; Liu H; Kang L
J Gastroenterol Hepatol; 2024 May; 39(5):858-867. PubMed ID: 38225773
[TBL] [Abstract][Full Text] [Related]
3. The Effect of (Chemo)Radiotherapy on Enlarged Lateral Lymph Nodes in Patients With Locally Advanced Rectal Cancer.
van der Zijden CJ; Schreurs HWH; van den Hoek S; van Geel AM; Dekker JWT; Roos D
Clin Colorectal Cancer; 2024 Jun; 23(2):128-134.e1. PubMed ID: 38735828
[TBL] [Abstract][Full Text] [Related]
4. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
5. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2024 May; 34(5):2963-2973. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
6. Influence of neoadjuvant treatment strategy on perioperative outcomes in locally advanced rectal cancer.
McFeetors C; O'Connell LV; Choy M; Dundon N; Regan M; Joyce M; Meshkat B; Hogan A; Nugent E
Colorectal Dis; 2024 Apr; 26(4):684-691. PubMed ID: 38424706
[TBL] [Abstract][Full Text] [Related]
7. Does complete pathological response increase perioperative morbidity risk in rectal cancer?
Tiang TKS; Yeoh ASS; Othman B; Mohan HM; Burgess AN; Smart PJ; Proud DM
Colorectal Dis; 2024 May; 26(5):916-925. PubMed ID: 38467575
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management.
Tchelebi LT; Romesser PB; Feuerlein S; Hoffe S; Latifi K; Felder S; Chuong MD
Cancer Control; 2020; 27(1):1073274820969449. PubMed ID: 33118384
[TBL] [Abstract][Full Text] [Related]
9. Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?
Shen Y; Wen Y; Bi L; Yang X; Gong X; Deng X; Meng W; Wang Z
Abdom Radiol (NY); 2024 Mar; 49(3):774-782. PubMed ID: 37999742
[TBL] [Abstract][Full Text] [Related]
10. The Enigma That is Rectal Squamous Cell Carcinoma: A Case Series.
Collie BL; Bello G; Hernandez AE; Sanchez LQ; Meece M; Lyons NB; Jackson A; Hui VW
J Surg Res; 2024 Jun; 298():335-340. PubMed ID: 38663259
[TBL] [Abstract][Full Text] [Related]
11. Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study.
Jooste V; Grosclaude P; Defossez G; Daubisse L; Woronoff AS; Bouvier V; Chirpaz E; Tretarre B; Lapotre B; Plouvier S; Launoy G; Bonneault M; Molinié F; Bouvier AM;
Dig Liver Dis; 2024 Jun; 56(6):1064-1070. PubMed ID: 37926634
[TBL] [Abstract][Full Text] [Related]
12. Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer.
Russo S; Anker CJ; Abdel-Wahab M; Azad N; Das P; Dragovic J; Goodman KA; Herman JM; Jones W; Kennedy T; Konski A; Kumar R; Lee P; Patel NM; Sharma N; Small W; Suh WW; Jabbour SK;
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):977-993. PubMed ID: 31445109
[TBL] [Abstract][Full Text] [Related]
13. Delayed treatment for rectal cancer.
Ristvedt SL; Birnbaum EH; Dietz DW; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2005 Sep; 48(9):1736-41. PubMed ID: 15981064
[TBL] [Abstract][Full Text] [Related]
14. Better Selection for Preoperative Treatment in Rectal Cancer.
Chang GJ
J Am Coll Surg; 2020 Oct; 231(4):425-426. PubMed ID: 32958137
[No Abstract] [Full Text] [Related]
15. Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
Healey Bird BRJ
Br J Surg; 2020 Dec; 107(13):1705-1707. PubMed ID: 33104240
[No Abstract] [Full Text] [Related]
16. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
[TBL] [Abstract][Full Text] [Related]
17. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
Lv Z; Liang Y; Liu H; Mo D
BMC Cancer; 2021 Mar; 21(1):306. PubMed ID: 33757442
[TBL] [Abstract][Full Text] [Related]
18. Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer.
Beard BW; Rettig RL; Ryoo JJ; Parker RA; McLemore EC; Attaluri V
J Am Coll Surg; 2020 Dec; 231(6):681-692. PubMed ID: 33121903
[TBL] [Abstract][Full Text] [Related]
19. International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
Denost Q; Solomon M; Tuech JJ; Ghouti L; Cotte E; Panis Y; Lelong B; Rouanet P; Faucheron JL; Jafari M; Lefevre JH; Rullier E; Heriot A; Austin K; Lee P; Brown W; Maillou-Martinaud H; Savel H; Quintard B; Broc G; Saillour-Glénisson F
Br J Surg; 2020 Dec; 107(13):1846-1854. PubMed ID: 32786027
[TBL] [Abstract][Full Text] [Related]
20. Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection.
He F; Ju HQ; Ding Y; Jiang Z; Li Z; Huang B; Wang X; Zhao Y; Li Y; Qi B; Luo W; Zhang Z; Pei Q; Chen H; Liu S; Pang X; Zheng J; Wang J; Ajani JA; Wan XB
Br J Cancer; 2020 Oct; 123(8):1244-1252. PubMed ID: 32724220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
